Journal profile · Medicine-Hematology
Oncogematologiya
ISSN 1818-8346 · eISSN 2413-4023 · ABV-press Publishing house, LLC · Russian Federation
Oncogematologiya: fully open access; no APC; review about 10 weeks (community reports); 54 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Oncogematologiya is published by ABV-press Publishing house, LLC. By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Acute Lymphoblastic Leukemia research, together about 36.2% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
The main purpose of the Oncohematology journal is to publish up-to-date information on clinical, experimental and fundamental scientific research, diagnostics and treatment options, as well as other materials on all relevant issues in oncohematology. The journal’s objectives are to inform various specialists who provide advisory and therapeutic assistance to patients with oncohematological diseases about current advances, including the latest methods for the diagnosis and treatment of malignant blood diseases. The journal is an interdisciplinary scientific publication uniting doctors of various specialties ‒ hematologists, oncologists, surgeons, radiation therapists, intensive care specialist, pathologists, etc. ‒ to form an interdisciplinary therapy approach in order to improve the treatment efficacy of patients with hematological malignancies.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Hematology
Editorial board by country: none in mainland China; most named Russia 26, United States 3, Austria 1 (30 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine15.3%
- Chronic Lymphocytic Leukemia ResearchMedicine11.9%
- Acute Lymphoblastic Leukemia researchMedicine9.1%
- Acute Myeloid Leukemia ResearchMedicine8.6%
- Multiple Myeloma Research and TreatmentsMedicine7.1%
- Hematopoietic Stem Cell TransplantationMedicine5.5%
- Neutropenia and Cancer InfectionsMedicine5%
- Hematological disorders and diagnosticsMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Hematology | Q4 | 128/151 | 15th |
| Oncology | Q4 | 367/428 | 14th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: RusSCI, ORCID
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.6LetPub ·
- SJR 2026-06
- 0.13LetPub ·
- SNIP 2026-06
- 0.22LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 15OpenAlex ·
- 2-year mean citedness
- 0.51OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 730 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 34 | 34 | 124 |
| 2025 | 54 | 54 | 149 |
| 2024 | 74 | 74 | 141 |
| 2023 | 62 | 62 | 177 |
| 2022 | 67 | 67 | 126 |
| 2021 | 45 | 45 | 91 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 10 weeksLetPub ·
- Peer review
- Double anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Keywords
- ≥ 3
- Reference style
- Vancouver
Article types accepted3
- lecturesContent: original articles, scientific reviews, lectures of the leading national and international specialists referred to new modern methods of blood diseases …Length not stated
- original articlesContent: original articles, scientific reviews, lectures of the leading national and international specialists referred to new modern methods of blood diseases …Length not stated
- scientific reviewsContent: original articles, scientific reviews, lectures of the leading national and international specialists referred to new modern methods of blood diseases …Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, License & copyright, Peer review, Plagiarism, Preprints, Self-archiving
- Authorship 6.2.1 Authorship and authors’ contributions
According to the recommendations of the ICMJE, the right to be referred as the author have those persons who made significant contribution to the conception and design of the study or in the data analysis and its interpretation, actively participated in drafting the article or making fundamental changes, participated in the final approval of the version that is to be published and ready to take re…
Source ↗Publisher website ·- Conflicts of interest 6.2.2 Conflict of interest
At the end of the article you must specify conflicts of interest for all authors. Conflict of interest implies the existence of any relations and/or personal interest that potentially can affect results, interpretation of data, its objective perception, such as financial relations and cooperation with any organizations (e.g., receipt of fees, educational grants, participation in expert councils, m…
Source ↗Publisher website ·- License & copyright Copyright Notice
Copyright retained by authors, first publication license to journal, CC BY license Model summary
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, addition…
Source ↗Publisher website ·- Peer review Peer Review Process
Peer-reviewed Model summary
A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of Onkogematologiya" (the “Oncohematology”). This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer. Members of the editorial board and leading Russian and international experts in correspon…
Source ↗Publisher website ·- Plagiarism Borrowing and Plagiarism
Publication of works containing plagiarism of text, ideas, data is prohibited. Authors should submit fully original works. Results of other authors’ work should be appropriately cited or quoted; quotations of a text previously published should be written as the direct speech with the obligatory indication of the original source. The editorial board of the journal checks the material using plagiari…
Source ↗Publisher website ·- Preprints Preprint and Postprint Policy
Prior to acceptance and publication in "Onkogematologiya" («Oncohematology»), authors may make their submissions available as preprints on personal or public websites. As part of submission process, authors are required to confirm that the submission has not been previously published, nor has been submitted. After a manuscript has been published in "Onkogematologiya" («Oncohematology») we suggest …
Source ↗Publisher website ·- Self-archiving
Preprint and self-archiving permitted and encouraged Model summary
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- ABV-press Publishing house, LLC
- Country or region
- Russian Federation
- Language
- Russian
- ISSN
- 1818-8346
- Electronic ISSN
- 2413-4023
- Latest issue on the website
- Volume 21, Issue 2 (2026)
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Oncogematologiya
How long does peer review take at Oncogematologiya?
Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Oncogematologiya?
According to the journal's author guidelines: Keywords: ≥ 3; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Oncogematologiya based?
Of the 30 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Russia (26), United States (3) and Austria (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Oncogematologiya?
According to LetPub and DOAJ records, Oncogematologiya is indexed in Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Oncogematologiya open access, and what is the APC?
Oncogematologiya is a fully open-access journal. It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .